Feature | December 05, 2014

Study Presented at RSNA Says Even Mild Coronary Artery Disease Puts Diabetic Patients at Risk

Researchers evaluated long-term prognostic value of CCTA in diabetic patients

December 5, 2014 — According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease. Results of the study were presented at RSNA 2014.

Researchers at the University of British Columbia and St. Paul's Hospital in Vancouver analyzed data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) Registry, which was developed to examine the prognostic value of cardiac computed tomography angiography (CCTA) for predicting adverse cardiac events related to coronary artery disease. The registry, which has CCTA data on 40,000 patients from 17 centers around the world, now has five-year follow-up data on 14,000 patients.

The researchers analyzed data on 1,823 diabetic patients who underwent CCTA to detect and determine the extent of coronary artery disease, in which a waxy substance called plaque builds up inside the arteries of the heart. This plaque buildup causes the artery wall to thicken, which limits or, in some cases, completely obstructs blood flow.

Men and women (median age 61.7) in the study were categorized as having no coronary artery disease, mild disease (less than 50 percent of coronary artery narrowed), or obstructive disease (more than 50 percent artery obstruction). Over a 5.2-year follow-up period, there were 246 deaths, representing 13.5 percent of the total study group.

Major adverse cardiovascular event (MACE) data was available on 973 patients. During the follow-up period, 295 (30.3 percent) of the patients experienced a MACE, such as heart attack or a procedure to re-open an obstructed artery called a coronary revascularization.

The researchers found that both obstructive and mild, or non-obstructive, coronary artery disease as determined by CCTA were related to patient deaths and MACE. The study found that the relative risk for death or MACE for a patient with mild coronary artery disease was comparable to that of patients with single vessel obstructive disease.

"Until now, two-year follow-up studies suggested that a diabetic patient with mild or non-obstructive coronary artery disease had a lower risk of major adverse cardiovascular events and death than patients with obstructive disease," said co-author Philipp Blanke, M.D., radiologist at the University of British Columbia and St. Paul's Hospital. "Our five-year follow-up data suggests that non-obstructive and obstructive coronary artery disease as detected by cardiac CTA in diabetic patients are both associated with higher rates of mortality."

Study observers say that researchers need a better understanding of the evolution of plaque in the arteries and patient response to therapies.

Researchers say that cardiac CT angiography is helpful for identifying diabetic patients who are at higher risk for heart events, who may benefit from more aggressive therapy to help modify that risk.

Co-authors on the study include Bruce Precious, M.D., Sasi R Ganga Raju, M.B.Ch.B.m Iksung Cho, M.S., Hyuk-Jae Chang, M.D., Fay Lin, M.D., Stephan Achenbach, M.D., Daniel S. Berman, M.D., Matthew J. Budoff, M.D., Tracy Q. Callister, M.D., Mouaz Al-Mallah, M.D., Filippo Cademartiri, M.D., Ph.D., Kavitha M. Chinnaiyan, M.D., Benjamin Chow, M.D., Allison Dunning, M.S., Augustin Delago, M.D., Todd C. Villines, M.D., Martin Hadamitzky, M.D., Jorg Hausleiter, M.D., Leslee Shaw, Ph.D., Philipp A. Kaufmann, M.D., Ricardo C. Cury, M.D., Gudrun Feuchtner, M.D., Yong-Jin Kim, M.D., Erica Maffei, M.D., Gilbert Raff, M.D., Gianluca Pontone, M.D., Daniele Andreini, M.D., Hugo M. Marques, M.D., Ronen Rubinshtein, M.D., Millie Gomez, M.D. and James K. Min, M.D.

For more information: www.rsna.org

Related Content

Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technology | Radiation Dose Management| September 07, 2017
September 7, 2017 — Sapheneia and Scannerside received U.S.
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
St. Cloud Hospital Installs Toshiba Aquilion One Genesis CT for Emergency Department
News | Computed Tomography (CT)| August 23, 2017
Central Minnesota residents now have access to advanced computed tomography (CT) technology that is safe and fast at St...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Technologies| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
3D printing of the heart and coronary artery tree from a patient's CT scan.
Sponsored Content | Webinar | 3-D Printing| August 09, 2017
Learn how 3-D printing empowers medical device manufacturer Medtronic to bring products to market faster, develop bet
Moffitt Cancer Center Enhances Patient Care with Toshiba Medical's Infinix-i 4-D
News | Interventional Radiology| August 03, 2017
Cancer patients at Moffitt Cancer Center in Tampa, Fla., now have access to advanced diagnostic imaging for fast and...
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Technologies| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Overlay Init